Jubilant Pharmova Limited

Jubilant Pharmova Limitedverified

JUBLPHARMA.BO

Price:

$1076.4

Market Cap:

$170.18B

Jubilant Pharmova Limited operates as an integrated pharmaceutical and life sciences company in India, the Americas, Europe, and internationally. It operates through six segments: Radiopharma, Allergy Immunotherapy, CDMO Sterile Injectables, Generics, Contract Research Development & Manufacturing Organisation (CRDMO), and Proprietary Novel Drugs. The Radiopharma segment offers radiopharmaceuticals products, which are used in the diagnosis and treatment of various diseases, including pulmonary embolism, cancer, coronary artery disease, and others. The Allergy Immunotherapy segment provides specialised diagnostic devices for skin testing, as well as venom immunotherapy products. The CDMO Steri...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2000-01-03

Stock Exchange

BSE

Ticker

JUBLPHARMA.BO

The PE Ratio as of December 2025 (TTM) for Jubilant Pharmova Limited (JUBLPHARMA.BO) is 35.84

According to Jubilant Pharmova Limited’s latest financial reports and current stock price. The company's current PE Ratio is 35.84. This represents a change of -4.04% compared to the average of 37.35 of the last 4 quarters.

Jubilant Pharmova Limited (JUBLPHARMA.BO) Historical PE Ratio (quarterly & annually)

How has JUBLPHARMA.BO PE Ratio performed in the past?

The mean historical PE Ratio of Jubilant Pharmova Limited over the last ten years is 17.95. The current 35.84 PE Ratio has changed 19.86% with respect to the historical average. Over the past ten years (40 quarters), JUBLPHARMA.BO's PE Ratio was at its highest in in the June 2023 quarter at 249.09. The PE Ratio was at its lowest in in the December 2022 quarter at -95.60.

Quarterly (TTM)
Annual

Average

17.95

Median

17.77

Minimum

-72.75

Maximum

118.23

Jubilant Pharmova Limited (JUBLPHARMA.BO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Jubilant Pharmova Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 222.62%

Maximum Annual PE Ratio = 118.23

Minimum Annual Increase = -587.32%

Minimum Annual PE Ratio = -72.75

Quarterly (TTM)
Annual
YearPE RatioChange
202517.35-85.32%
2024118.23-262.51%
2023-72.75-587.32%
202214.93-20.99%
202118.89222.62%
20205.86-67.81%
201918.19-11.41%
201820.54-5.22%
201721.6730.37%
201616.62-139.46%

Jubilant Pharmova Limited (JUBLPHARMA.BO) Average PE Ratio

How has JUBLPHARMA.BO PE Ratio performed in the past?

The current PE Ratio of Jubilant Pharmova Limited (JUBLPHARMA.BO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

20.94

5-year avg

19.33

10-year avg

17.95

Jubilant Pharmova Limited (JUBLPHARMA.BO) PE Ratio vs. Peers

How is JUBLPHARMA.BO’s PE Ratio compared to its peers?

Jubilant Pharmova Limited’s PE Ratio is greater than Alembic Pharmaceuticals Limited (27.88), greater than Alembic Pharmaceuticals Limited (27.88), less than Eris Lifesciences Limited (50.87), greater than Caplin Point Laboratories Limited (25.35), less than Eris Lifesciences Limited (50.87), greater than NATCO Pharma Limited (9.85), greater than NATCO Pharma Limited (9.85), greater than Granules India Limited (26.55), greater than Granules India Limited (26.55), less than Poly Medicure Limited (53.18),

Build a custom stock screener for Jubilant Pharmova Limited (JUBLPHARMA.BO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Jubilant Pharmova Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Jubilant Pharmova Limited (JUBLPHARMA.BO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Jubilant Pharmova Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Jubilant Pharmova Limited's PE Ratio?

How is the PE Ratio calculated for Jubilant Pharmova Limited (JUBLPHARMA.BO)?

What is the highest PE Ratio for Jubilant Pharmova Limited (JUBLPHARMA.BO)?

What is the 3-year average PE Ratio for Jubilant Pharmova Limited (JUBLPHARMA.BO)?

What is the 5-year average PE Ratio for Jubilant Pharmova Limited (JUBLPHARMA.BO)?

How does the current PE Ratio for Jubilant Pharmova Limited (JUBLPHARMA.BO) compare to its historical average?